JP2023522038A5 - - Google Patents

Info

Publication number
JP2023522038A5
JP2023522038A5 JP2022562711A JP2022562711A JP2023522038A5 JP 2023522038 A5 JP2023522038 A5 JP 2023522038A5 JP 2022562711 A JP2022562711 A JP 2022562711A JP 2022562711 A JP2022562711 A JP 2022562711A JP 2023522038 A5 JP2023522038 A5 JP 2023522038A5
Authority
JP
Japan
Prior art keywords
hinge
ccr
item
car
hinge region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022562711A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522038A (ja
JP7802684B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/027648 external-priority patent/WO2021211948A1/en
Publication of JP2023522038A publication Critical patent/JP2023522038A/ja
Publication of JP2023522038A5 publication Critical patent/JP2023522038A5/ja
Priority to JP2025106623A priority Critical patent/JP2025129196A/ja
Application granted granted Critical
Publication of JP7802684B2 publication Critical patent/JP7802684B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022562711A 2020-04-17 2021-04-16 修飾ｃｃｒポリペプチド及びその使用 Active JP7802684B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025106623A JP2025129196A (ja) 2020-04-17 2025-06-24 修飾ｃｃｒポリペプチド及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063011494P 2020-04-17 2020-04-17
US63/011,494 2020-04-17
PCT/US2021/027648 WO2021211948A1 (en) 2020-04-17 2021-04-16 Modified ccr polypeptides and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025106623A Division JP2025129196A (ja) 2020-04-17 2025-06-24 修飾ｃｃｒポリペプチド及びその使用

Publications (3)

Publication Number Publication Date
JP2023522038A JP2023522038A (ja) 2023-05-26
JP2023522038A5 true JP2023522038A5 (https=) 2024-04-25
JP7802684B2 JP7802684B2 (ja) 2026-01-20

Family

ID=78084154

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022562711A Active JP7802684B2 (ja) 2020-04-17 2021-04-16 修飾ｃｃｒポリペプチド及びその使用
JP2025106623A Pending JP2025129196A (ja) 2020-04-17 2025-06-24 修飾ｃｃｒポリペプチド及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025106623A Pending JP2025129196A (ja) 2020-04-17 2025-06-24 修飾ｃｃｒポリペプチド及びその使用

Country Status (8)

Country Link
US (1) US20240261404A1 (https=)
EP (1) EP4136119A4 (https=)
JP (2) JP7802684B2 (https=)
KR (1) KR20230005147A (https=)
CN (1) CN115397864A (https=)
AU (1) AU2021255702A1 (https=)
CA (1) CA3180329A1 (https=)
WO (1) WO2021211948A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023549079A (ja) * 2020-10-30 2023-11-22 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 二重標的化キメラ抗原受容体
CA3255500A1 (en) 2022-04-08 2023-10-12 Regeneron Pharmaceuticals, Inc. MULTI-PART RECEIVERS AND SIGNALING COMPLEXES
CN119403825A (zh) * 2022-05-17 2025-02-07 阿森纳生物科学公司 靶向psma和ca9的工程化受体的系统
USD1066799S1 (en) * 2022-08-12 2025-03-11 Kiss Nail Products, Inc. Applicator for artificial eyelashes
IL322949A (en) 2023-03-03 2025-10-01 Arsenal Biosciences Inc Systems targeting PSMA and CA9

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
ES2602743T3 (es) * 2010-09-08 2017-02-22 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Receptores de antígenos quiméricos con una región bisagra optimizada
GB201513540D0 (en) * 2015-07-31 2015-09-16 King S College London Therapeutic agents
EP3336107A1 (en) * 2016-12-15 2018-06-20 Miltenyi Biotec GmbH Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor
CN113286811B (zh) * 2018-07-30 2024-12-06 南加利福尼亚大学 改善过继性细胞疗法的效力和安全性
EP3632461A1 (en) * 2018-10-05 2020-04-08 St. Anna Kinderkrebsforschung A group of chimeric antigen receptors (cars)
EP3632460A1 (en) * 2018-10-05 2020-04-08 St. Anna Kinderkrebsforschung A group of chimeric antigen receptors (cars)
EP3860642A1 (en) * 2018-10-05 2021-08-11 St. Anna Kinderkrebsforschung A group of chimeric antigen receptors (cars)
CN113474012B (zh) * 2019-01-25 2023-09-08 湖南远泰生物技术有限公司 Epcam抗体和epcam-car-t细胞
WO2020252110A1 (en) * 2019-06-14 2020-12-17 Bluebird Bio, Inc. Compositions and methods for treating cancer

Similar Documents

Publication Publication Date Title
JP2023522038A5 (https=)
JP7487112B2 (ja) Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用
AU2021307614B2 (en) Engineered immune cell for allotransplantation
JP6633081B2 (ja) 細胞
JP7767502B2 (ja) Ｎｋ阻害性分子を発現する遺伝子改変免疫細胞とその使用
JP2022537159A5 (https=)
US20200038443A1 (en) Multi-function and multi-targeting car system and methods for use thereof
EP4219693A1 (en) Chimeric antigen receptor targeting cd7 and use thereof
JP2021514631A5 (https=)
JP2020500530A5 (https=)
JP2017504601A5 (https=)
US20230028399A1 (en) Bcma-directed cellular immunotherapy compositions and methods
CN114015656A (zh) 用于同种异体移植的工程化免疫细胞
JP2022513460A5 (https=)
JP2015527070A5 (https=)
EP4194472A1 (en) Chimeric antigen receptor comprising novel co-stimulatory domain and use thereof
JP2024534471A5 (https=)
JP2024525727A5 (https=)
CN117187185A (zh) 一种工程化免疫细胞及其用途
CN117004604A (zh) 一种ciita基因被敲除的工程化免疫细胞及其用途
Weiner et al. Antibodies and cancer therapy: versatile platforms for cancer immunotherapy
EP4663762A2 (en) Immune rejection-resistant engineered cell
US20210079111A1 (en) Cd19-cd20 bispecific and dual passway car-t and methods for use thereof
CN117430712A (zh) 靶向cxcr6的嵌合抗原受体及其用途
WO2023241141A1 (zh) 靶向ccr8的嵌合抗原受体及其用途